ArticleTranslational cancer research2026
A weakly supervised deep learning model for OSCC diagnosis and lesion highlighting in histopathology images.
Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Oral squamous cell carcinoma (OSCC) is the predominant histopathological subtype of oral malignancies, and histopathology-based diagnosis remains central to clinical management. With the rapid development of digital pathology and deep learning, automated analysis of histopathology images has shown considerable potential for improving screening efficiency and reducing inter-observer variability. However, in both public datasets and real-world research settings, only image-level labels are commonly available, whereas region-level annotations are often lacking. This limitation makes weakly supervised modeling necessary and also restricts rigorous validation of spatial interpretability. Methods: To address these challenges, we developed a weakly supervised deep learning framework based on patch-level representation learning and multiple-instance aggregation for image-level OSCC diagnosis with exploratory heatmap visualization. Specifically, histopathology images were divided into patches and encoded into feature embeddings. UNI 2, a recently developed pathology foundation model with highly competitive performance in contemporary computational pathology benchmarks, was adopted as the primary feature extractor to obtain informative patch representations. ResNet-50 was additionally implemented as a conventional baseline encoder for comparative evaluation. A self-attention-based multiple-instance aggregation module was then introduced to capture dependencies among instances within each patch set and to generate binary OSCC predictions. Results: In five-fold cross-validation, the UNI-2-based model achieved a mean area under the curve (AUC) of 0.9919, compared with 0.9899 for the ResNet-50 baseline. On the independent external validation cohort, UNI 2 further achieved an AUC of 0.9992, outperforming ResNet-50, which achieved an AUC of 0.9564. As an exploratory interpretability analysis, attention responses were visualized as heatmaps to inspect model focus patterns and support qualitative error review, without assuming verified lesion-level correspondence in the absence of region-level annotations. Conclusions: This framework demonstrates strong image-level diagnostic performance for OSCC and provides exploratory visualization for qualitative model review without requiring additional fine-grained annotations, offering a reusable technical pathway for weakly supervised OSCC histopathology modeling and future multicenter validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.